LICENSE AGREEMENT BY AND BETWEEN PROCESSA PHARMACEUTICALS, INC. AND ELION ONCOLOGY, INC DATED AS OF AUGUST 23, 2020License Agreement • September 17th, 2020 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 17th, 2020 Company Industry JurisdictionTHIS LICENSE AGREEMENT is entered into as of this 23 day of August, 2020 (the “Effective Date”), by and between Processa Pharmaceuticals, Inc. a corporation organized under the laws of Delaware, having a business address at 7380 Coca Cola Drive, Suite 106, Hanover, MD 21076 (“Processa”), and Elion Oncology, Inc. a corporation organized under the laws of Maryland whose principal place of business is at 4800 Hampden Lane, Bethesda, MD 20814 (“Elion”).
LICENSE AGREEMENT BY AND BETWEEN PROCESSA PHARMACEUTICALS, INC. AND ELION ONCOLOGY, INC DATED AS OF AUGUST 23, 2020License Agreement • August 27th, 2020 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 27th, 2020 Company Industry JurisdictionTHIS LICENSE AGREEMENT is entered into as of this 23 day of August, 2020 (the “Effective Date”), by and between Processa Pharmaceuticals, Inc. a corporation organized under the laws of Delaware, having a business address at 7380 Coca Cola Drive, Suite 106, Hanover, MD 21076 (“Processa”), and Elion Oncology, Inc. a corporation organized under the laws of Maryland whose principal place of business is at 4800 Hampden Lane, Bethesda, MD 20814 (“Elion”).